Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 1998. Start Trial.
Date Value
November 20, 2026 522.84M
November 19, 2026 550.09M
November 18, 2026 600.27M
November 17, 2026 606.14M
November 16, 2026 568.71M
November 13, 2026 584.88M
November 12, 2026 602.27M
November 11, 2026 619.02M
November 10, 2026 589.52M
November 09, 2026 603.88M
November 06, 2026 599.57M
November 05, 2026 573.99M
November 04, 2026 657.68M
November 03, 2026 561.04M
November 02, 2026 560.46M
October 30, 2026 538.11M
October 29, 2026 571.48M
October 28, 2026 585.84M
October 27, 2026 702.77M
October 26, 2026 702.77M
October 23, 2026 683.45M
October 22, 2026 689.89M
October 21, 2026 709.22M
October 20, 2026 760.75M
October 19, 2026 734.98M
Date Value
October 16, 2026 715.66M
October 15, 2026 754.31M
October 14, 2026 728.54M
October 13, 2026 734.98M
October 12, 2026 747.87M
October 09, 2026 751.09M
October 08, 2026 747.87M
October 07, 2026 734.98M
October 06, 2026 741.43M
October 05, 2026 741.43M
October 02, 2026 734.98M
October 01, 2026 741.43M
September 30, 2026 754.31M
September 29, 2026 745.69M
September 28, 2026 752.12M
September 25, 2026 758.54M
September 24, 2026 758.54M
September 23, 2026 745.69M
September 22, 2026 790.67M
September 21, 2026 784.24M
September 18, 2026 784.24M
September 17, 2026 797.09M
September 16, 2026 777.82M
September 15, 2026 790.67M
September 14, 2026 829.22M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Agenus, Inc. 453.57M
Amgen, Inc. 276.45B
Anika Therapeutics, Inc. 158.39M
BioCryst Pharmaceuticals, Inc. 2.302B
Imunon, Inc. 6.224M